Let Data Have a GIANT™ Impact
on the Success of Your Clinical Trials

We are the premier eCOA, digital evidence capture and clinical insights generation platform used in clinical trials today

The only purpose-built, single source code platform unifying data collection, AI-driven insights, and remediation for CNS trials

Core Features

How GIANT™ Transforms Clinical Trials

GIANT™ is EMAW’s unique, single code eCOA platform which has been on the market since 2018 and is currently being used in over 25 countries by more than 250 clinical research sites. With near real time data access, automated QC rules and visibility at the level of individual site, subject, and rater, GIANT™ acts as a resource multiplier for study sponsors and CROs.

The core elements of the platform are:

01

Gather

Collect and integrate all primary, secondary and exploratory measures (eCOA, EMA, sensors, wearables, audio, video). Use hundreds of available APIs to bring in third party data sets, including EMRs, EHRs, e-clinical platforms and structured real world databases.

02

Insights

Expert – designed rules are configured to review data as it is updated daily, with prespecified findings triggering time-based notifications, flags and alerts. To further enhance quality, AI transcription and review provide 100% coverage for large audio/video data files.

03

Adjudicate

Targeted workflows: Detect potential issues and take remediation actions before they affect trial quality.
 

04

Navigate

Advanced business intelligence: Interrogate data to build custom models and extract sponsor-specific insights beyond pre-configured analytics.

05

Track

Full audit trails: Every keystroke logged, with automated compliance reports for sponsors/CROs.